arXiv Science⌕ Search

arXiv subjects

Emma Dann

Publications and source records attributed to Emma Dann.

2 recordsLinked to original sources

DiscoveryAgent: A Framework for Scientist-centric Agentic AI

AI agents can assist scientific research, but balancing autonomous investigation with scientists' ability to inspect and redirect ongoing work remains a central design challenge. We present DiscoveryAgent, a domain-agnostic, scientist-centric system that combines autonomous investigation with scientist-directed hypothesis steering. Scientists select, refine, or replace hypotheses between research rounds, while audit agents interrogate checkpointed records to trace claims, reproduce analyses, and inform subsequent decisions. Across two predictive modeling tasks, DiscoveryAgent produced the best variable-star classifier among evaluated baselines and, with scientist steering, a protein variant-effect predictor surpassed by only one of 106 ProteinGym baselines. We develop a rigorous checkpointing system that enables highly capable audit agents, a scalable form of oversight for agentic research. Audit agents autonomously identify errors at higher rates than previous AI scientist agents, and scientists collaborating with audit agents identify 14x more valid errors versus scientists performing manual review. In three case studies led by domain experts across physical science, social science, and life science, we developed a multimodal photometric-redshift estimator that resolves complementary failures of images and photometry, achieving 0.971 AUROC for low-redshift classification; documented an 83% rise in Florida homeowners-insurance premiums from 2013 to 2023, with a growing, regressive burden; and identified CD4+ T-cell relay genes, which both receive and exert broad transcriptional regulation, enriched for autoimmune disease associations. Together, these results show how autonomous research can expand scientists' empirical reach while centering their authority over research direction and their ability to understand and challenge the evidence.

cs.AI↗

Modelling Technical and Biological Effects in scRNA-seq data with Scalable GPLVMs

Single-cell RNA-seq datasets are growing in size and complexity, enabling the study of cellular composition changes in various biological/clinical contexts. Scalable dimensionality reduction techniques are in need to disentangle biological variation in them, while accounting for technical and biological confounders. In this work, we extend a popular approach for probabilistic non-linear dimensionality reduction, the Gaussian process latent variable model, to scale to massive single-cell datasets while explicitly accounting for technical and biological confounders. The key idea is to use an augmented kernel which preserves the factorisability of the lower bound allowing for fast stochastic variational inference. We demonstrate its ability to reconstruct latent signatures of innate immunity recovered in Kumasaka et al. (2021) with 9x lower training time. We further analyze a COVID dataset and demonstrate across a cohort of 130 individuals, that this framework enables data integration while capturing interpretable signatures of infection. Specifically, we explore COVID severity as a latent dimension to refine patient stratification and capture disease-specific gene expression.

cs.LG↗